Patent details
EP3323830 Title: ANTI-GD2 ANTIBODIES
Basic Information
- Publication number:
- EP3323830
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP171914518
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTI-GD2 ANTIBODIES
- French Title of Invention:
- ANTICORPS ANTI-GD2
- German Title of Invention:
- ANTI-GD2-ANTIKÖRPER
- SPC Number:
Dates
- Filing date:
- 20/06/2011
- Grant date:
- 23/08/2023
- EP Publication Date:
- 23/05/2018
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/08/2023
- EP B1 Publication Date:
- 23/08/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 20/06/2024
- Expiration date:
- 20/06/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/08/2023
- Name:
- Memorial Sloan-Kettering Cancer Center
- Address:
- 1275 York Avenue, New York, NY 10065, United States (US)
Inventor
1
- Name:
- Ahmed, Mahiuddin
- Address:
- United States (US)
2
- Name:
- Cheung, Nai-Kong
- Address:
- United States (US)
Priority
- Priority Number:
- 397920 P
- Priority Date:
- 19/06/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07K 16/00; A61K 39/395; C12N 5/07;
Publication
European Patent Bulletin
1
- Issue number:
- 202334
- Publication date:
- 23/08/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202335
- Publication date:
- 30/08/2023
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|